COCCIOLONE, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 453
EU - Europa 350
AS - Asia 133
SA - Sud America 4
OC - Oceania 3
Totale 943
Nazione #
US - Stati Uniti d'America 450
IE - Irlanda 97
IT - Italia 82
CN - Cina 73
SE - Svezia 57
TR - Turchia 39
DE - Germania 36
UA - Ucraina 26
GB - Regno Unito 19
VN - Vietnam 10
FI - Finlandia 8
RU - Federazione Russa 7
FR - Francia 6
IN - India 6
TH - Thailandia 4
AU - Australia 3
CA - Canada 3
BE - Belgio 2
PT - Portogallo 2
RO - Romania 2
BG - Bulgaria 1
BR - Brasile 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
GR - Grecia 1
ID - Indonesia 1
MC - Monaco 1
PE - Perù 1
PL - Polonia 1
RS - Serbia 1
Totale 943
Città #
Chandler 108
Dublin 97
Jacksonville 96
Wilmington 29
Izmir 22
Nanjing 22
L'aquila 17
Ashburn 16
New York 14
Boardman 13
Bremen 13
Lawrence 13
Princeton 13
Beijing 11
Dong Ket 8
Houston 8
Milan 8
Redwood City 8
Shenyang 8
Ann Arbor 7
Rome 7
San Mateo 7
Falls Church 6
Hebei 5
Jinan 5
Woodbridge 5
Aquila 4
Dearborn 3
Kunming 3
London 3
Mountain View 3
Nanchang 3
Pescara 3
Songkhla 3
Sydney 3
Tianjin 3
Brussels 2
Bucharest 2
Columbia 2
Guangzhou 2
Hanoi 2
Moscow 2
Pune 2
Seattle 2
Taizhou 2
Verona 2
Antalya 1
Arielli 1
Arzignano 1
Athens 1
Bangkok 1
Belluno 1
Fremont 1
Grafing 1
Haikou 1
Hefei 1
Istanbul 1
Jiaxing 1
Katowice 1
Kazan 1
Lappeenranta 1
Lima 1
Los Angeles 1
Monaco 1
Norwalk 1
Onalaska 1
Palermo 1
Poli 1
Qingdao 1
Red Deer 1
Saint Petersburg 1
San Francisco 1
Shanghai 1
Stockholm 1
Tallinn 1
Tappahannock 1
Toronto 1
Washington 1
Yekaterinburg 1
Zhengzhou 1
Épinay-sous-sénart 1
Totale 652
Nome #
Breast cancer and psychological resilience among young women 194
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 92
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 91
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 89
Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer 78
Dose-dense nonpegylated liposomal doxorubicin and docetaxel combination in breast cancer: Dose-finding study 77
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting 74
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 62
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 62
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 45
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience 42
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice 41
Looking for a place for dose-dense TMZ regimens in GBM patients: An experience with MGMT exploratory evaluation 35
Totale 982
Categoria #
all - tutte 3.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.034


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201936 0 0 0 0 0 0 0 0 0 3 0 33
2019/2020134 21 3 16 5 2 12 32 8 18 2 2 13
2020/2021160 1 14 1 15 17 7 16 12 20 8 23 26
2021/202297 6 1 27 8 6 4 3 7 6 0 5 24
2022/2023293 13 28 2 46 33 25 0 16 120 1 5 4
2023/202458 6 3 1 4 10 29 0 4 0 1 0 0
Totale 982